[1]
|
Murray, C.J.L. (2022) The Global Burden of Disease Study at 30 Years. Nature Medicine, 28, 2019-2026. https://doi.org/10.1038/s41591-022-01990-1
|
[2]
|
Tsao, C.W., Aday, A.W., Almarzooq, Z.I., et al. (2022) Heart Disease and Stroke Statistics-2022 Update: A Report from the American Heart Association. Circulation, 145, e153-e639.
|
[3]
|
Krack, A., Richartz, B.M., Gastmann, A., Greim, K., Lotze, U., Anker, S.D., et al. (2004) Studies on Intragastric PCO2 at Rest and during Exercise as a Marker of Intestinal Perfusion in Patients with Chronic Heart Failure. European Journal of Heart Failure, 6, 403-407. https://doi.org/10.1016/j.ejheart.2004.03.002
|
[4]
|
Sandek, A., Swidsinski, A., Schroedl, W., Watson, A., Valentova, M., Herrmann, R., et al. (2014) Intestinal Blood Flow in Patients with Chronic Heart Failure: A Link with Bacterial Growth, Gastrointestinal Symptoms, and Cachexia. Journal of the American College of Cardiology, 64, 1092-1102. https://doi.org/10.1016/j.jacc.2014.06.1179
|
[5]
|
李奇林, 覃汉荣, 熊俊. 提高消化系统在危重症救治中的认识[J]. 中华普通外科学文献(电子版), 2010, 4(2): 91-94.
|
[6]
|
McDonagh, T.A., Metra, M., Adamo, M., Gardner, R.S., Baumbach, A., Böhm, M., et al. (2021) 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure: Developed by the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC) with the Special Contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal, 42, 3599-3726. https://doi.org/10.1093/eurheartj/ehab368
|
[7]
|
Tang, W.H.W., Li, D.Y. and Hazen, S.L. (2018) Dietary Metabolism, the Gut Microbiome, and Heart Failure. Nature Reviews Cardiology, 16, 137-154. https://doi.org/10.1038/s41569-018-0108-7
|
[8]
|
Deftereos, S., Giannopoulos, G., Panagopoulou, V., Bouras, G., Raisakis, K., Kossyvakis, C., et al. (2014) Anti-Inflammatory Treatment with Colchicine in Stable Chronic Heart Failure: A Prospective, Randomized Study. JACC: Heart Failure, 2, 131-137. https://doi.org/10.1016/j.jchf.2013.11.006
|
[9]
|
Kemp, C.D. and Conte, J.V. (2012) The Pathophysiology of Heart Failure. Cardiovascular Pathology, 21, 365-371. https://doi.org/10.1016/j.carpath.2011.11.007
|
[10]
|
Mahmud, M. and Champion, H.C. (2007) Right Ventricular Failure Complicating Heart Failure: Pathophysiology, Significance, and Management Strategies. Current Cardiology Reports, 9, 200-208. https://doi.org/10.1007/bf02938351
|
[11]
|
Felker, G.M., Lee, K.L., Bull, D.A., Redfield, M.M., Stevenson, L.W., Goldsmith, S.R., et al. (2011) Diuretic Strategies in Patients with Acute Decompensated Heart Failure. New England Journal of Medicine, 364, 797-805. https://doi.org/10.1056/nejmoa1005419
|
[12]
|
Sax, D.R., Mark, D.G., Rana, J.S., Reed, M.E., Lindenfeld, J., Stevenson, L.W., et al. (2022) Current Emergency Department Disposition of Patients with Acute Heart Failure: An Opportunity for Improvement. Journal of Cardiac Failure, 28, 1545-1559. https://doi.org/10.1016/j.cardfail.2022.05.006
|
[13]
|
Zhang, Y., Wang, Y., Ke, B. and Du, J. (2021) TMAO: How Gut Microbiota Contributes to Heart Failure. Translational Research, 228, 109-125. https://doi.org/10.1016/j.trsl.2020.08.007
|
[14]
|
Pasini, E., Aquilani, R., Testa, C., Baiardi, P., Angioletti, S., Boschi, F., et al. (2016) Pathogenic Gut Flora in Patients with Chronic Heart Failure. JACC: Heart Failure, 4, 220-227. https://doi.org/10.1016/j.jchf.2015.10.009
|
[15]
|
Kato, M., Stevenson, L.W., Palardy, M., Campbell, P.M., May, C.W., Lakdawala, N.K., et al. (2012) The Worst Symptom as Defined by Patients during Heart Failure Hospitalization: Implications for Response to Therapy. Journal of Cardiac Failure, 18, 524-533. https://doi.org/10.1016/j.cardfail.2012.04.012
|
[16]
|
Arutyunov, G.P., Kostyukevich, O.I., Serov, R.A., Rylova, N.V. and Bylova, N.A. (2008) Collagen Accumulation and Dysfunctional Mucosal Barrier of the Small Intestine in Patients with Chronic Heart Failure. International Journal of Cardiology, 125, 240-245. https://doi.org/10.1016/j.ijcard.2007.11.103
|
[17]
|
李可. 慢性心力衰竭中医证型与肠道菌群相关性研究[J]. 中国中西医结合杂志, 2018, 38(6): 654-658.
|
[18]
|
陈可冀, 吴宗贵, 朱明军, 等. 慢性心力衰竭中西医结合诊疗专家共识[J]. 心脑血管病防治, 2016, 16(5): 340-347.
|
[19]
|
毛静远, 朱明军. 慢性心力衰竭中医诊疗专家共识[J]. 中医杂志, 2014, 55(14): 1258-1260.
|
[20]
|
高红勤. 关于“二阳之病发心脾”之认识[J]. 中国中医药现代远程教育, 2009, 7(12): 14-15.
|
[21]
|
郭佳易, 贺丰杰, 李楠. 基于“二阳之病发心脾”探讨肠道微生物群与不孕症的关系[J]. 北京中医药大学学报, 2023, 46(6): 836-841.
|
[22]
|
尹涛, 孙睿睿, 何昭璇, 等. 略论“大肠小肠皆属于胃” [J]. 湖南中医杂志, 2016, 32(11): 138-140.
|
[23]
|
Katsimichas, T., Antonopoulos, A.S., Katsimichas, A., Ohtani, T., Sakata, Y. and Tousoulis, D. (2019) The Intestinal Microbiota and Cardiovascular Disease. Cardiovascular Research, 115, 1471-1486. https://doi.org/10.1093/cvr/cvz135
|
[24]
|
Saffouri, G.B., Shields-Cutler, R.R., Chen, J., Yang, Y., Lekatz, H.R., Hale, V.L., et al. (2019) Small Intestinal Microbial Dysbiosis Underlies Symptoms Associated with Functional Gastrointestinal Disorders. Nature Communications, 10, Article No. 2012. https://doi.org/10.1038/s41467-019-09964-7
|
[25]
|
Parthasarathy, G., Chen, J., Chen, X., Chia, N., O’Connor, H.M., Wolf, P.G., et al. (2016) Relationship between Microbiota of the Colonic Mucosa vs Feces and Symptoms, Colonic Transit, and Methane Production in Female Patients with Chronic Constipation. Gastroenterology, 150, 367-379.e1. https://doi.org/10.1053/j.gastro.2015.10.005
|
[26]
|
Ohkusa, T., Koido, S., Nishikawa, Y. and Sato, N. (2019) Gut Microbiota and Chronic Constipation: A Review and Update. Frontiers in Medicine, 6, Article No. 19. https://doi.org/10.3389/fmed.2019.00019
|
[27]
|
Jia, Q., Li, H., Zhou, H., Zhang, X., Zhang, A., Xie, Y., et al. (2019) Role and Effective Therapeutic Target of Gut Microbiota in Heart Failure. Cardiovascular Therapeutics, 2019, Article ID: 5164298. https://doi.org/10.1155/2019/5164298
|
[28]
|
Nendl, A., Raju, S.C., Broch, K., Mayerhofer, C.C.K., Holm, K., Halvorsen, B., et al. (2023) Intestinal Fatty Acid Binding Protein Is Associated with Cardiac Function and Gut Dysbiosis in Chronic Heart Failure. Frontiers in Cardiovascular Medicine, 10, Article ID: 1160030. https://doi.org/10.3389/fcvm.2023.1160030
|
[29]
|
Yan, H. and Ajuwon, K.M. (2017) Butyrate Modifies Intestinal Barrier Function in IPEC-J2 Cells through a Selective Upregulation of Tight Junction Proteins and Activation of the Akt Signaling Pathway. PLOS ONE, 12, e0179586. https://doi.org/10.1371/journal.pone.0179586
|
[30]
|
Kelley, N., Jeltema, D., Duan, Y. and He, Y. (2019) The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation. International Journal of Molecular Sciences, 20, Article No. 3328. https://doi.org/10.3390/ijms20133328
|
[31]
|
Simrén, M., Barbara, G., Flint, H.J., Spiegel, B.M.R., Spiller, R.C., Vanner, S., et al. (2012) Intestinal Microbiota in Functional Bowel Disorders: A Rome Foundation Report. Gut, 62, 159-176. https://doi.org/10.1136/gutjnl-2012-302167
|
[32]
|
Rezaie, A., Buresi, M., Lembo, A., Lin, H., McCallum, R., Rao, S., et al. (2017) Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus. American Journal of Gastroenterology, 112, 775-784. https://doi.org/10.1038/ajg.2017.46
|
[33]
|
霍星宇, 耿婕. 肠道菌群及其代谢产物与心血管疾病关系的研究进展[J]. 天津医药, 2020, 48(5): 460-464.
|
[34]
|
Mamic, P., Chaikijurajai, T. and Tang, W.H.W. (2021) Gut Microbiome—A Potential Mediator of Pathogenesis in Heart Failure and Its Comorbidities: State-of-the-Art Review. Journal of Molecular and Cellular Cardiology, 152, 105-117. https://doi.org/10.1016/j.yjmcc.2020.12.001
|
[35]
|
Salzano, A., Cassambai, S., Yazaki, Y., Israr, M.Z., Bernieh, D., Wong, M., et al. (2022) The Gut Axis Involvement in Heart Failure: Focus on Trimethylamine N-Oxide. Cardiology Clinics, 40, 161-169. https://doi.org/10.1016/j.ccl.2021.12.004
|
[36]
|
卢林, 杨景云, 李丹红. 健脾渗湿汤对脾虚湿盛泄泻患者肠道微生态及舌部菌群影响的研究[J]. 中国微生态学杂志, 2007, 19(5): 439-441.
|